News & Updates

Nivolumab continues positive OS, ORR track record in advanced RCC

05 Mar 2020 by

Patients with previously treated advanced or metastatic clear cell renal cell carcinoma (RCC) appear to derive greater overall survival (OS) benefit with nivolumab compared with everolimus, according to final results of the phase III CheckMate 025* trial presented at ASCO GU 2020.

Nivolumab continues positive OS, ORR track record in advanced RCC

05 Mar 2020

High-dose methylprednisolone safe, effective in severe Mycoplasma pneumoniae pneumonia

05 Mar 2020

Treatment with high-dose methylprednisolone is effective against severe Mycoplasma pneumoniae pneumonia (SMPP) and does not increase the incidence of adverse reactions, suggests a study.

High-dose methylprednisolone safe, effective in severe Mycoplasma pneumoniae pneumonia

05 Mar 2020

Ozone pollution may increase risk of death

05 Mar 2020 by

A short-term association exists between ozone pollution and mortality, a multi-country study has found, noting that ozone-related deaths can be prevented under stricter air quality standards in line with the World Health Organization (WHO) guidelines.

Ozone pollution may increase risk of death

05 Mar 2020

Pioglitazone lowers mortality risk in insulin-treated T2DM patients

05 Mar 2020

Use of pioglitazone is associated with reduced risks of all-cause mortality and noncardiovascular (non-CV) death among patients with type 2 diabetes mellitus (T2DM) who are undergoing insulin therapy, a recent study has shown.

Pioglitazone lowers mortality risk in insulin-treated T2DM patients

05 Mar 2020

Women sleep better than men

05 Mar 2020 by

Across almost all age groups, women appear to have longer sleep duration and better sleep quality than men, according to a recent study.

Women sleep better than men

05 Mar 2020

Low-dose IL-2 may render therapeutic benefit for SLE

05 Mar 2020 by

Low-dose interleukin (IL)-2 therapy may be effective for the treatment of active systemic lupus erythematosus (SLE), a study has shown.

Low-dose IL-2 may render therapeutic benefit for SLE

05 Mar 2020

Omega-3 fatty acid infusions do not protect against complications in liver surgery

05 Mar 2020

The infusion of two single doses of Omega-3 polyunsaturated fatty acids before and after liver surgery does not appear to reduce the risk of complications, a new study has found.

Omega-3 fatty acid infusions do not protect against complications in liver surgery

05 Mar 2020

Water pills confer benefits to overweight, obese OSA patients with hypertension

05 Mar 2020 by

Diuretics appear to be useful in the treatment of obstructive sleep apnoea (OSA) in overweight or moderately obese patients with hypertension, producing reductions in OSA severity, body weight and blood pressure, as reported in a recent study.

Water pills confer benefits to overweight, obese OSA patients with hypertension

05 Mar 2020

Realizing the potential of stereotactic ablative radiotherapy for primary renal cell carcinoma

05 Mar 2020 by

Stereotactic ablative radiotherapy (SABR) has shown promising results in primary renal cell carcinoma (RCC) in recent trials and has become a treatment option for patients with inoperable primary RCC or tumours in solitary kidney, said Dr Shankar Siva of the Peter MacCallum Cancer Centre of Melbourne, Australia, at the Uro-Oncology Asia 2020 conference.

Realizing the potential of stereotactic ablative radiotherapy for primary renal cell carcinoma

05 Mar 2020

Low rheumatoid factor at CZP discontinuation predicts remission maintenance in RA

05 Mar 2020

Rheumatoid arthritis (RA) patients who exhibit low rheumatoid factor (RF), as well as low disease activity, following treatment with certolizumab pegol (CZP) plus methotrexate (MTX) may be able to discontinue CZP without the increased risk of loss of remission, a recent study has shown.

Low rheumatoid factor at CZP discontinuation predicts remission maintenance in RA

05 Mar 2020

News & Updates

Filter by Specialty:

Specialty:

Nivolumab continues positive OS, ORR track record in advanced RCC

Nivolumab continues positive OS, ORR track record in advanced RCC

High-dose methylprednisolone safe, effective in severe Mycoplasma pneumoniae pneumonia

High-dose methylprednisolone safe, effective in severe Mycoplasma pneumoniae pneumonia

Ozone pollution may increase risk of death

Ozone pollution may increase risk of death

Pioglitazone lowers mortality risk in insulin-treated T2DM patients

Pioglitazone lowers mortality risk in insulin-treated T2DM patients

Women sleep better than men

Women sleep better than men

Low-dose IL-2 may render therapeutic benefit for SLE

Low-dose IL-2 may render therapeutic benefit for SLE

Omega-3 fatty acid infusions do not protect against complications in liver surgery

Omega-3 fatty acid infusions do not protect against complications in liver surgery

Water pills confer benefits to overweight, obese OSA patients with hypertension

Water pills confer benefits to overweight, obese OSA patients with hypertension

Realizing the potential of stereotactic ablative radiotherapy for primary renal cell carcinoma

Realizing the potential of stereotactic ablative radiotherapy for primary renal cell carcinoma

Low rheumatoid factor at CZP discontinuation predicts remission maintenance in RA

Low rheumatoid factor at CZP discontinuation predicts remission maintenance in RA